118 completed. 118 Phase 3, 26 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 118 | Completed 118 |
| Phase 2 | 26 | Completed 26 |
Follow Shock: new trials by email Literature Review of Shock trials Research Report on Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjunctive Methylene Blue in Septic Shock Methylene Blue, Usual Care - Septic Shock | Phase 3 | Completed | Dr. Shannon M. Fernando | 50 | 2025-06-02 | 2026-03-19 |
| Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery Dalargin, 0.9 % NaCl - Postoperative Complications, Multiple Organ Failure | Phase 3 | Completed | Botkin Hospital | 200 | 2025-05-13 | 2026-09-23 |
| A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) VBI-S - Septic Shock, Sepsis | Phase 3 | Completed | Vivacelle Bio | 39 | 2024-08-06 | 2026-10-26 |
| Methylene Blue for the Treatment of Septic Shock Methylene Blue, Placebo - Septic Shock | Phase 3 | Completed | Northern Jiangsu People's Hospital | 88 | 2024-08-05 | 2026-02-04 |
| The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock Norepinephrine, Ringer's Lactate - Septic Shock, Sepsis | Phase 2 / Phase 3 | Completed | Universitas Indonesia | 42 | 2024-03-25 | 2024-06-20 |
| Multimodal Vasopressor Strategy in Septic Shock Simultaneous administration of vasopressors, Successive administration of vasopressors - Shock, Septic | Phase 2 / Phase 3 | Completed | University Medical Centre Maribor | 79 | 2023-12-23 | 2026-03-31 |
| Strong Albumin Solutions in Patients With Septic Shock hyperoncotic human albumin solution, Buffered crystalloid solutions - Sepsis, Septic Shock | Phase 2 / Phase 3 | Completed | Manchester University NHS Foundation Trust | 47 | 2023-11-10 | 2026-02-09 |
| Low Dose Versus High Dose Methylene Blue in Septic Patients Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock | Phase 2 / Phase 3 | Completed | National Cancer Institute, Egypt | 90 | 2023-08-01 | 2024-07-05 |
| Trauma Resuscitation With Low-Titer Group O Whole Blood or Products LTOWB, Components - Wounds and Injuries, Shock, Hemorrhagic | Phase 3 | Completed | University of Alabama at Birmingham | 1100 | 2023-07-27 | 2026-09-22 |
| The Effect Of Resuscitation Guided By Two Different Dynamic Parameters On Time To Normalization Of The Capillary Refill Time In Adult Patients With Septic Shock Group VTI, Group IVC - Septic Shock, Resuscitation | Phase 3 | Completed | Kasr El Aini Hospital | 90 | 2023-07-21 | 2025-04-29 |
| Fibrinogen Early In Severe Trauma StudY II Fibrinogen Concentrate, Cryoprecipitate - Trauma, Haemorrhagic Shock | Phase 3 | Completed | Australian and New Zealand Intensive Care Research Centre | 900 | 2022-11-21 | 2026-09-09 |
| Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure Norepinephrine, Lactated Ringers, Intravenous, normal saline - Respiratory Failure, Hypotension and Shock | Phase 3 | Completed | Wright State University | 42 | 2022-08-09 | 2024-07-15 |
| Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial low titer whole blood, Standard Care - Hemorrhagic Shock, Traumatic Injury | Phase 3 | Completed | Jason Sperry | 1020 | 2022-04-19 | 2026-02-12 |
| Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients Routine labs - Hemorrhagic Shock, Acute Blood Loss Anemia | Phase 3 | Completed | Loma Linda University | 199 | 2022-03-05 | 2025-08-08 |
| Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock Oxygen gas - Cardiogenic Shock, Extracorporeal Membrane Oxygenation | Phase 3 | Completed | Centre Hospitalier Universitaire de Besancon | 60 | 2022-01-09 | 2024-12-30 |
| Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital cyclosporine - COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome | Phase 3 | Completed | Alexandria University | 66 | 2022-01-03 | 2025-05-14 |
| Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two. 5% Albumin (human) Solution, Paeds solution - Burns | Phase 2 / Phase 3 | Completed | King Edward Medical University | 90 | 2022-01-01 | 2024-01-25 |
| LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients Levosimendan, Placebo of Levosimendan - Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 206 | 2021-08-27 | 2025-03-21 |
| Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments Vitamin C, Normal saline - Sepsis, Septic Shock | Phase 3 | Completed | Universitaire Ziekenhuizen KU Leuven | 301 | 2021-06-01 | 2024-01-25 |
| Ivabradine for Heart Rate Control In Septic Shock Ivabradine, Placebo - Septic Shock | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 429 | 2021-02-26 | 2026-09-03 |
Showing 20 of 118. Sign in to see all of them.
Shock, Septic (71) · Sepsis (48) · Shock, Hemorrhagic (11) · COVID-19 (8) · Cytokine Release Syndrome (7) · Multiple Organ Failure (6) · Shock, Cardiogenic (6) · Wounds and Injuries (6) · Critical Illness (5) · Pneumonia (5) · Systemic Inflammatory Response Syndrome (5) · Adrenal Insufficiency (4) · Diabetes Insipidus (4) · Hemorrhage (4)
Pathological Conditions, Signs and Symptoms (118) · Pathologic Processes (115) · Inflammation (83) · Infections (82) · Systemic Inflammatory Response Syndrome (80) · Sepsis (29) · Respiratory Tract Diseases (19) · Lung Diseases (15) · Cardiovascular Diseases (14) · Vascular Diseases (14) · Respiratory Tract Infections (13) · Coronaviridae Infections (8) · Endocrine System Diseases (8) · Nidovirales Infections (8)
Saline Solution (13) · Hydrocortisone (12) · Sodium Chloride (10) · Norepinephrine (7) · Ringer's Lactate (7) · Ascorbic Acid (5) · Albumins (4) · Methylene Blue (4) · Standard of Care (4) · Hydroxyethyl Starch Derivatives (3) · Injections (3) · Tranexamic Acid (3) · Vasopressins (3) · Ceftriaxone (2) · Clarithromycin (2)
Assistance Publique - Hôpitaux de Paris (6) · University of Versailles (4) · Australian and New Zealand Intensive Care Research Centre (2) · Beth Israel Deaconess Medical Center (2) · Cairo University (2) · Centre Hospitalier Universitaire de Besancon (2) · Cristina Martinez (2) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (2) · Frisius Medisch Centrum (2) · Hospices Civils de Lyon (2) · Kompetenznetz Sepsis (2) · McMaster University (2) · Northern Jiangsu People's Hospital (2) · Novartis Pharmaceuticals (2) · University Hospital, Grenoble (2)
France (33) · United States (23) · Germany (13) · Italy (13) · Canada (12) · Spain (11) · Belgium (10) · United Kingdom (10) · Australia (7) · Netherlands (7) · Brazil (6) · Egypt (6) · Austria (5) · Russia (5) · China (4)
Konrad Reinhart, MD (3) · Anders Perner, MD, PhD (2) · Andrea Morelli, MD (2) · Didier Keh, MD (2) · Djillali Annane, MD (2) · Djillali Annane, MD, PhD (2) · Luciano Gattinoni, MD (2) · Michael W Donnino, MD (2) · Pietro Caironi, MD (2) · Qingquan Lyu, Master (2) · Thomas Deufel, MD (2) · Abdelrhman Hussein (1) · Ahmed Mukhtar, Professor (1)
PMID 23984731, PMID 24635772, PMID 25647203, PMID 33438477, PMID 38531812, PMID 40271704, PMID 10933646, PMID 16757723, PMID 16978417, PMID 17109736, PMID 17720019, PMID 18090009, PMID 18184957, PMID 18184958, PMID 18444850, PMID 18552688, PMID 19114908, PMID 19730258, PMID 19851126, PMID 20103758, PMID 20200382, PMID 20562702, PMID 20594297, PMID 20610825, PMID 20826251, PMID 20924555, PMID 21112053, PMID 21129208, PMID 21332727, PMID 21516036, PMID 21615299, PMID 21827677, PMID 21926601, PMID 21929764, PMID 22073145, PMID 22564837, PMID 22616830, PMID 22692171, PMID 22738085, PMID 23322670, PMID 23352693, PMID 23353941, PMID 23512062, PMID 23525934, PMID 24037226, PMID 24108515, PMID 24207137, PMID 24292991, PMID 24335442, PMID 24794878
2005 (3), 2017 (2), 2018 (2), 2019 (2), 1UG3HL157401-01A1 (1), 2009 (1), 2014 (1), K23GM083211 (1), R01HD101528 (1), R01HL043167 (1), R01HL049970 (1), U01HL077863 (1), U24HL157310 (1)